ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.04
0.60%
US Tech 100
17,442.00
2.14%
S&P 500
5,127.79
1.26%
US Dollar vs CAD
1.36715
0.00%
Bitcoin
62,908.86
0.03%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ProQR Therapeutics NV (PRQR)

  7. ProQR Therapeutics NV (PRQR) News

PRQR

ProQR Therapeutics NV (PRQR)

ProQR Therapeutics NV
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRQR
DateTimeSourceHeadlineSymbolCompany
02/15/20246:46AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
02/14/20245:08AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRQRProQR Therapeutics NV
02/09/20245:37AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRQRProQR Therapeutics NV
01/19/20246:08AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
01/05/20246:08AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
11/07/20239:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
09/27/20236:06AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
09/14/20234:20PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PRQRProQR Therapeutics NV
08/03/20236:15AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
08/01/20236:15AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
05/16/20236:16AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
04/25/20235:06AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRQRProQR Therapeutics NV
04/24/20233:31PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PRQRProQR Therapeutics NV
03/29/20233:55PMEdgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:PRQRProQR Therapeutics NV
03/29/20233:54PMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:PRQRProQR Therapeutics NV
03/29/20233:08PMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PRQRProQR Therapeutics NV
03/10/20233:10PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
02/14/20239:14AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
02/09/20234:01PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
02/09/202311:33AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
02/09/202310:59AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
02/08/20235:02AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
12/23/20223:40PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
12/23/20226:11AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
11/10/20225:35AMTipRanksProQR (PRQR) Gets a Buy from H.C. WainwrightNASDAQ:PRQRProQR Therapeutics NV
11/09/20222:40PMTipRanksAnalysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
11/09/20226:04AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
09/21/20223:17PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
08/11/20228:15PMTipRanksChardan Capital downgrades ProQR (PRQR) to a HoldNASDAQ:PRQRProQR Therapeutics NV
08/11/20227:37AMTipRanksProQR (PRQR) was downgraded to a Hold Rating at JMP SecuritiesNASDAQ:PRQRProQR Therapeutics NV
 Showing the most relevant articles for your search:NASDAQ:PRQR

Your Recent History

USOTC
MWWC
Marketing Worldwide (PK)
USOTC
BLLB
Bell Buckle (PK)
USOTC
TKMO
Tekumo (PK)
USOTC
HMBL
HUMBL (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
RDGL
Vivos (QB)
USOTC
YCRM
Yuenglings Ice Cream (PK)
USOTC
UATG
Umbra Applied Technologies (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
INQD
Indoor Harvest (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
MGON
Megola (PK)
USOTC
ASRE
Astra Energy (QB)
USOTC
SPZI
Spooz (PK)
NYSE
AMC
AMC Entertainment
USOTC
ASKH
Astika (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved